COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,308 Articles (22,772 medRxiv, 8,536 bioRxiv)

Most recent first Previous |  Page 457: Articles 4561-4570  | Next

Safety and Immunogenicity of the NVX-CoV2373 Vaccine as a Booster in Adults Previously Vaccinated with the BBIBP-CorV Vaccine: An Interim Analysis
Toback, S., Marchese, A. M., Warren, B., Ayman, S., Zarkovic, S., ElTantawy, I., Mallory, R. M., Rousculp, M., Almarzooqi, F., Piechowski-Jozwiak, B., Bonilla, M.-F., Bakkour, A. E., Hussein, S. E., Al Kaabi, N.
10.1101/2023.03.24.23287658 — Posted: 2023-03-29
Early real world evidence on the relative SARS-COV-2 vaccine effectiveness of bivalent COVID-19 booster doses: a rapid review.
Sane Schepisi, M.
10.1101/2023.03.28.23287762 — Posted: 2023-03-29
mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients
Perkins, G. B., Tunbridge, M. J., Chai, C. S., Hope, C. M., Yeow, A. E. L., Salehi, T., Singer, J. J., Shi, B., Masavuli, M., Mekonnen, Z., Garcia-Valtanen, P., Kireta, S., Johnston, J. K., Drogemuller, C. J., Sim, B. Z., Spencer, S. M., Sallustio, B., Comerford, I., Bouras, G., Weiskopf, D., Sette, A., Aggarwal, A., Akerman, A., Milogiannakis, V., Turville, S. G., Hurtado, P. R., Ying, T., Hissaria, P., Barry, S. C., Chadban, S. J., Grubor-Bauk, B., Coates, T.
10.1101/2023.03.27.23287773 — Posted: 2023-03-29
Health-related quality of life and adherence to lifestyle recommendations in schoolchildren during the COVID-19 pandemic: results from the longitudinal cohort study Ciao Corona
Haile, S. R., Gunz, S., Peralta, G. P., Ulyte, A., Raineri, A., Rueegg, S., Yasenok, V., Radtke, T., Puhan, M. A., Kriemler, S.
10.1101/2023.03.27.23287611 — Posted: 2023-03-29
Real time analysis of SARS-CoV-2 induced cytolysis reveals distinct variant-specific replication profiles
Scheuermann, S. E., Goff, K. A., Rowe, L. A., Beddingfield, B. J., Maness, N. J.
10.1101/2023.03.28.534588 — Posted: 2023-03-28
An App-Based Ecological Momentary Assessment of Undergraduate Mental Health During the COVID-19 pandemic in Canada (Smart Healthy Campus Version 2.0): Longitudinal Study
Brogly, C., Lizotte, D. J., Mitchell, M., Speechley, M., MacDougall, A., Huner, E., Anderson, K. K., Bauer, M. A.
10.1101/2023.03.22.23287598 — Posted: 2023-03-28
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Galanis, P. A., Katsiroumpa, A., Vraka, I., Chrysagi, V., Siskou, O., Konstantakopoulou, O., Katsoulas, T., Gallos, P., Kaitelidou, D.
10.1101/2023.03.27.23287816 — Posted: 2023-03-28
SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling
Dies, B., de Lucas-Rius, A., Mendoza, L., Garcia, T., Fernandez, R., Suarez, J. M., Milhano, F., Corrales, F., Redondo, N., Pedrucci, F., Zaldivar, S., Jimenez, M. A., Montoya, M., Garrido, J. J.
10.1101/2023.03.27.534381 — Posted: 2023-03-27
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Van Damme, K. F. A., Hoste, L., Declercq, J., De Leeuw, E., Maes, B., Martens, L., Colman, R., Browaeys, R., Bosteels, C., Verwaerde, S., Vermeulen, N., Lameire, S., Debeuf, N., Deckers, J., Stordeur, P., Guilliams, M., Schetters, S., Haerynck, F., Tavernier, S. J., Lambrecht, B. N.
10.1101/2023.03.25.23287712 — Posted: 2023-03-27
Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: the four-way decomposition analysis
Djuric, O., Larosa, E., Cassinadri, M., Cilloni, S., Bisaccia, E., Pepe, D., Bonvicini, L., Vicentini, M., Venturelli, F., Giorgi Rossi, P., Pezzotti, P., Mateo Urdiales, A., Bedeschi, E.
10.1101/2023.03.27.23287795 — Posted: 2023-03-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).